Alina Iovleva

1.3k total citations
26 papers, 876 citations indexed

About

Alina Iovleva is a scholar working on Molecular Medicine, Endocrinology and Pharmacology. According to data from OpenAlex, Alina Iovleva has authored 26 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Medicine, 14 papers in Endocrinology and 10 papers in Pharmacology. Recurrent topics in Alina Iovleva's work include Antibiotic Resistance in Bacteria (21 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Vibrio bacteria research studies (7 papers). Alina Iovleva is often cited by papers focused on Antibiotic Resistance in Bacteria (21 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Vibrio bacteria research studies (7 papers). Alina Iovleva collaborates with scholars based in United States, Japan and Italy. Alina Iovleva's co-authors include Yohei Doi, Robert A. Bonomo, Ryan K. Shields, Christi L. McElheny, Ellen G Kline, Akito Kawai, Michael R. Jacobs, Mark D. Adams, Meredith S. Wright and Nadim G. El Chakhtoura and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

Alina Iovleva

25 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alina Iovleva United States	13	735	291	263	189	182	26	876
Laura J. Rojas United States	16	746 1.0×	301 1.0×	213 0.8×	186 1.0×	189 1.0×	48	893
Jesabel I. Rivera United States	9	721 1.0×	197 0.7×	300 1.1×	170 0.9×	222 1.2×	10	842
Alessandro Capone Italy	17	838 1.1×	354 1.2×	253 1.0×	241 1.3×	250 1.4×	25	1.0k
Viola Conte Italy	14	804 1.1×	209 0.7×	355 1.3×	113 0.6×	188 1.0×	17	915
André Birgy France	18	698 0.9×	254 0.9×	372 1.4×	137 0.7×	229 1.3×	48	1.1k
Chaitra Shankar India	16	709 1.0×	156 0.5×	269 1.0×	117 0.6×	163 0.9×	42	826
Agila Kumari Pragasam India	19	611 0.8×	189 0.6×	284 1.1×	158 0.8×	143 0.8×	52	886
Christi L. McElheny United States	19	854 1.2×	274 0.9×	283 1.1×	92 0.5×	303 1.7×	46	1.0k
Lynette Phee United Kingdom	15	720 1.0×	263 0.9×	296 1.1×	89 0.5×	130 0.7×	27	872
Luigi Principe Italy	19	878 1.2×	414 1.4×	305 1.2×	213 1.1×	273 1.5×	63	1.1k

Countries citing papers authored by Alina Iovleva

Since Specialization

Citations

This map shows the geographic impact of Alina Iovleva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alina Iovleva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alina Iovleva more than expected).

Fields of papers citing papers by Alina Iovleva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alina Iovleva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alina Iovleva. The network helps show where Alina Iovleva may publish in the future.

Co-authorship network of co-authors of Alina Iovleva

This figure shows the co-authorship network connecting the top 25 collaborators of Alina Iovleva. A scholar is included among the top collaborators of Alina Iovleva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alina Iovleva. Alina Iovleva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shields, Ryan K., Giusy Tiseo, Alessandro Leonildi, et al.. (2024). Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections. JAC-Antimicrobial Resistance. 6(5). dlae146–dlae146. 12 indexed citations

Iovleva, Alina, Christi L. McElheny, Eric Cober, et al.. (2024). In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals. Antimicrobial Agents and Chemotherapy. 68(3). e0125823–e0125823. 15 indexed citations

Iovleva, Alina, Vance G. Fowler, & Yohei Doi. (2024). Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections. Drugs. 85(1). 21–40. 10 indexed citations

Stellfox, Madison E., Hayley R. Nordstrom, Yanhong Li, et al.. (2024). Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates. Journal of Antimicrobial Chemotherapy. 79(4). 801–809. 4 indexed citations

McElheny, Christi L., Alina Iovleva, D. R. Woods, et al.. (2024). Prevalence and features of hypervirulent Klebsiella pneumoniae in respiratory specimens at a US hospital system. Infection and Immunity. 93(1). e0048624–e0048624. 3 indexed citations

Heil, Emily L., Kimberly C. Claeys, Ellen G Kline, et al.. (2023). Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients. Journal of Antimicrobial Chemotherapy. 78(4). 1034–1040. 16 indexed citations

Iovleva, Alina, Christi L. McElheny, Ellen G Kline, et al.. (2023). 2134. Impact of ADC ß-lactamase amino acid variation on cefiderocol (FDC) susceptibility in carbapenem-resistant Acinetobacter baumannii (CRAb) strains. Open Forum Infectious Diseases. 10(Supplement_2).

Iovleva, Alina, Mustapha M. Mustapha, M. Patrick Griffith, et al.. (2022). Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance. mBio. 13(2). e0275921–e0275921. 60 indexed citations

Evans, Daniel R., Christi L. McElheny, Alina Iovleva, et al.. (2022). Isolation and Characterization of Lytic Bacteriophages Targeting Diverse Enterobacter spp. Clinical Isolates. PubMed. 3(1). 50–58. 5 indexed citations

10.

Nordstrom, Hayley R., Daniel R. Evans, Paula F. Zamora, et al.. (2022). Genomic characterization of lytic bacteriophages targeting genetically diverse Pseudomonas aeruginosa clinical isolates. iScience. 25(6). 104372–104372. 24 indexed citations

11.

Lebreton, François, Brendan W. Corey, Christi L. McElheny, et al.. (2021). Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseri. Antimicrobial Agents and Chemotherapy. 65(7). e0015021–e0015021. 15 indexed citations

12.

Jiménez, Adriana, Lilian M. Abbo, Octavio Martínez, et al.. (2020). KPC-3–ProducingSerratia marcescensOutbreak between Acute and Long-Term Care Facilities, Florida, USA. Emerging infectious diseases. 26(11). 2746–2750. 11 indexed citations

13.

Shields, Ryan K., Alina Iovleva, Ellen G Kline, et al.. (2020). Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to Cefepime. Clinical Infectious Diseases. 71(10). 2713–2716. 68 indexed citations

14.

Kawai, Akito, Christi L. McElheny, Alina Iovleva, et al.. (2020). Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol in Enterobacter cloacae Due to AmpC R2 Loop Deletion. Antimicrobial Agents and Chemotherapy. 64(7). 66 indexed citations

15.

Babiker, Ahmed, Nupur Gupta, Connie Fe C. Gibas, et al.. (2019). Rasamsonia sp: An emerging infection amongst chronic granulomatous disease patients. A case of disseminated infection by a putatively novel Rasamsonia argillacea species complex involving the heart. Medical Mycology Case Reports. 24. 54–57. 14 indexed citations

16.

Iovleva, Alina, Roberta T. Mettus, Christi L. McElheny, et al.. (2019). High-Level Carbapenem Resistance in OXA-232-Producing Raoultella ornithinolytica Triggered by Ertapenem Therapy. Antimicrobial Agents and Chemotherapy. 64(1). 10 indexed citations

17.

Iovleva, Alina, Roberta T. Mettus, Christi L. McElheny, et al.. (2019). Reduced ceftazidime and ertapenem susceptibility due to production of OXA-2 in Klebsiella pneumoniae ST258. Journal of Antimicrobial Chemotherapy. 74(8). 2203–2208. 5 indexed citations

18.

Iovleva, Alina & Yohei Doi. (2017). Carbapenem-Resistant Enterobacteriaceae. Clinics in Laboratory Medicine. 37(2). 303–315. 184 indexed citations

19.

Wright, Meredith S., Alina Iovleva, Michael R. Jacobs, Robert A. Bonomo, & Mark D. Adams. (2016). Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment. Genome Medicine. 8(1). 26–26. 56 indexed citations

20.

Iovleva, Alina, Federico Pérez, Steve H. Marshall, et al.. (2016). Ceftazidime/Avibactam and Ceftolozane/Tazobactam in Treatment of Pulmonary Infections by Imipenem Resistant Pseudomonas aeruginosa. Open Forum Infectious Diseases. 3(suppl_1). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact